Radionuclide imaging in the diagnosis of osteoid osteoma

  • Authors:
    • Jong Hoon Park
    • Kisoo Pahk
    • Sungeun Kim
    • Soon Hyuck Lee
    • Sang Heon Song
    • Jae Gol Choe
  • View Affiliations

  • Published online on: May 25, 2015     https://doi.org/10.3892/ol.2015.3258
  • Pages: 1131-1134
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oseteoid osteoma is a well-known type of benign bone-forming tumor, which has previously been diagnosed using plain radiograph imaging. However, diagnosis of osteoid osteoma may be delayed due to ambiguities on plain radiograph images; despite the increasing use of magnetic resonance imaging (MRI), this type of misdiagnosis is not uncommon. The aim of the present study was to evaluate the effectiveness of radionuclide imaging scans for the diagnosis of osteoid osteoma, as this form of imaging was proposed to be a more sensitive test. The characteristics of 18 cases of osteoid osteoma were analyzed based on diagnostic imaging and the time from initial recognition of symptoms by the patient to diagnosis. Diagnostic modalities included plain radiograph, computed tomography (CT), MRI and radionuclide imaging. Among the 18 patients, 14 patients had unique positive findings in plain radiographs. The mean duration between initial cognition of symptoms to the diagnosis for these patients was 5.2 months (range, 3.8‑9.3 months). A total of 4 patients exhibited no radiographic abnormalities in the initial plain radiographs and were diagnosed a mean of 18.5 months (range, 17‑20 months) following the onset of symptoms. Overall, radionuclide imaging was performed on 16 patients and all of the cases demonstrated positive findings. In these cases, 28.6% of osteoid osteoma patients with clinical indications revealed no abnormal findings in plain radiographs. Therefore, in situations such as these, radionuclide imaging may be a useful indicator for diagnosis, as these results have demonstrated that it positively identified all cases of osteoid osteoma. In addition, the results of the present study indicated that if the radionuclide imaging was positive, CT scan was a more valuable diagnostic tool, whereas if the radionuclide imaging was negative, MRI should be recommended for the diagnosis of other undiscovered disease entities.
View Figures
View References

Related Articles

Journal Cover

August-2015
Volume 10 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park JH, Pahk K, Kim S, Lee SH, Song SH and Choe JG: Radionuclide imaging in the diagnosis of osteoid osteoma. Oncol Lett 10: 1131-1134, 2015
APA
Park, J.H., Pahk, K., Kim, S., Lee, S.H., Song, S.H., & Choe, J.G. (2015). Radionuclide imaging in the diagnosis of osteoid osteoma. Oncology Letters, 10, 1131-1134. https://doi.org/10.3892/ol.2015.3258
MLA
Park, J. H., Pahk, K., Kim, S., Lee, S. H., Song, S. H., Choe, J. G."Radionuclide imaging in the diagnosis of osteoid osteoma". Oncology Letters 10.2 (2015): 1131-1134.
Chicago
Park, J. H., Pahk, K., Kim, S., Lee, S. H., Song, S. H., Choe, J. G."Radionuclide imaging in the diagnosis of osteoid osteoma". Oncology Letters 10, no. 2 (2015): 1131-1134. https://doi.org/10.3892/ol.2015.3258